The a7nAChR agonist GTS-21 significantly attenuates hyperoxic acute lung injury and increases bacterial clearance

Text Registration

The a7nAChR agonist GTS-21 significantly attenuates hyperoxic acute lung injury and increases bacterial clearance

Status

Published

on 22 Mar 2016

Year of Creation

2015

Ravikumar Sitapara

Registration Number

TX0008221388

on 22 Mar 2016

The U.S. Copyright record (Registration Number: TX0008221388) dated 22 Mar 2016, pertains to an electronic file (eService) titled "The a7nAChR agonist GTS-21 significantly attenuates hyperoxic acute lung injury and increases bacterial clearance" created in 2015. The copyright holder is Ravikumar Sitapara, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Ravikumar Sitapara.

Ravikumar Sitapara

Application Details

Registration Number

TX0008221388

Registration Date

3/22/2016

Year of Creation

2015

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Ravikumar Sitapara

Notes

Rights Note: Diana G Zajic, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600 xext77020, disspub@proquest.com

Statements

Application Title Statement: The a7nAChR agonist GTS-21 significantly attenuates hyperoxic acute lung injury and increases bacterial clearance

Author Statement: Ravikumar Sitapara Citizenship: India Authorship: text

Notes

Rights Note: Diana G Zajic, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600 xext77020, disspub@proquest.com

Statements

Application Title Statement: The a7nAChR agonist GTS-21 significantly attenuates hyperoxic acute lung injury and increases bacterial clearance

Author Statement: Ravikumar Sitapara Citizenship: India Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.